Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 40.80
+0.25 (0.62%)
Aug 19, 2026, 1:42 PM CST
Ttbio Market Cap
Ttbio has a market cap or net worth of 1.16 billion as of August 19, 2026. Its market cap has increased by 165.77% in one year.
Market Cap
1.16B
Enterprise Value
1.28B
Revenue
433.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.80
ChartMarket Cap Chart
Since January 8, 2015, Ttbio's market cap has decreased from 1.19B to 1.16B, a decrease of -2.82%. That is a compound annual growth rate of -0.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 1.22B | 49.63% |
| Dec 31, 2025 | 814.36M | 70.16% |
| Dec 30, 2024 | 478.60M | -8.92% |
| Dec 26, 2023 | 525.49M | -19.22% |
| Dec 28, 2022 | 650.55M | 21.30% |
| Dec 30, 2021 | 536.32M | 2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maxigen Biotech | 3.61B |
| ICARES Medicus | 3.46B |
| Nang Kuang Pharmaceutical | 3.22B |
| Crystalvue Medical | 1.90B |
| Chi Sheng Pharma & Biotech | 1.80B |
| BenQ Medical Technology | 1.75B |
| Lagis Enterprise | 1.20B |
| Concord Medical | 1.05B |